Olubukola Ayodele: Deeply appreciative of the chance to serve as a Trustee for CupArise CIO
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a post by CupArise CIO on LinkedIn, adding:
“I am deeply appreciative of the chance to serve as a Trustee for CupArise CIO, an inspiring charity that plays a pivotal role in transforming the lives of women.
CupArise is committed to empowering women by providing vital information and resources that enable them to make timely decisions regarding their breast health. One of the flagship initiatives, the Mami App, is specifically designed to break down the barriers that prevent early detection of breast cancer.
By offering accessible tools and information, the app aims to enhance support and connect users to healthcare resources, particularly in low-income countries where these services are often lacking. This innovative approach not only raises awareness but also significantly improves health outcomes for women who might otherwise face significant challenges in accessing care.
Founded by Mercy Ofuya — a distinguished medical statistician and the proud winner of the 2023 Vanessa Moss Prize—CupArise is grounded in expertise and a passion for making a difference.
As I embark on this journey with CupArise, I am excited about the possibilities ahead and am committed to enhancing the well-being and health outcomes of women globally. Together, we can create a future where every woman has the knowledge and support necessary to prioritize her breast health.”
CupArise CIO shared on LinkedIn:
“We are delighted to welcome Olubukola Ayodele to our board of trustees.
She is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, UK and is the Head of Breast Cancer Unit at the Leicester Cancer Research Centre.
Her extensive clinical and research experience, and passion for global cancer control through research, training and advocacy will be invaluable in leading CupArise CIO through our next growth phase.
We are really looking forward to working with her on the Mami app project for breast health awareness to enhance early presentation of breast cancer patients.
We are all excited for the journey ahead!”
More posts featuring Olubukola Ayodele on oncodaily.com
Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre. Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023